COVID-19 and Influenza A+B Antigen Combo Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A and Influenza B virus antigens present in human nasopharyngeal swab specimens that can be performed with the use of the LF Reader.
Product Features
Fast results
Simple Operation (Less Training Required)
Objective (Results Read by Analyzer)
High Accuracy
PRODUCT SPECIFICATION
- PrincipleChromatographic Immunoassay
- FormatCassette
- SpecimenNasopharyngeal Swab
- CertificateCE
- Reading Time15 minutes
- Pack20 T
-
Storage Temperature
2-30°C
- Shelf Life2 Years
- Sensitivity97.1%(COVID-19) / 95.0%(Influenza A) / 92.9%(Influenza B)
- Specificity99.1%(COVID-19) / 99.1%(Influenza A) / 99.1%(Influenza B)
- Accuracy98.2%(COVID-19) / 98.4%(Influenza A) / 98.1%(Influenza B)
Ordering Information
- Cat. No.ICIC-R525
- ProductCOVID-19 and Influenza A+B Antigen Combo Rapid Test
- SpecimenNasopharyngeal Swab
- Pack20 T
- Cut-Off-
